The Wegovy Pill vs Injection: Cost and Value Compared
The oral Wegovy tablet (oral semaglutide 25mg) is available from about $149/month for qualifying patients, while injectable Wegovy self-pay runs ~$349/month via NovoCare. The pill suits needle-averse patients; the injection has the deeper evidence base. The oral tablet suits needle-averse patients who can follow its strict empty-stomach timing, while the injection has the deeper weight-loss evidence base; both are FDA-approved semaglutide, unlike compounded alternatives.
- Oral Wegovy from ~$149/mo (qualifying patients); injectable ~$349/mo self-pay.
- Oral semaglutide requires a much higher dose due to poor absorption.
- Both are FDA-approved semaglutide; the injection has more weight-loss trial data.
- Choice depends on cost, needle preference, and clinical fit.
The cost comparison
The oral Wegovy tablet, containing oral semaglutide, is available from about $149 per month for qualifying patients through NovoCare, making it one of the cheaper FDA-approved semaglutide routes. Injectable Wegovy self-pay runs about $349 per month through the same program.
For an uninsured patient who wants an FDA-approved product, the oral tablet can be substantially cheaper than the injection while still delivering an approved medication rather than a compounded one.
Insured pricing depends on your plan and can be lower than either cash figure.
Why the pill needs a higher dose
Oral semaglutide is poorly absorbed through the gut, so the oral products use a much higher dose than the injection to achieve comparable blood levels. The oral weight-management dose is 25mg daily, versus 2.4mg weekly for the injection.
This absorption challenge is also why the oral tablet must be taken on an empty stomach with specific timing rules. Following the instructions matters for the drug to work.
It is a genuinely different pharmacokinetic situation, not simply the same drug in pill form.
| Attribute | Oral tablet | Injection |
|---|---|---|
| Dose | 25mg daily | 2.4mg weekly |
| Self-pay/mo | from $149 | ~$349 |
| Administration | Pill, empty stomach | Weekly injection |
| Evidence | OASIS trials | STEP, SELECT |
The evidence base
Injectable semaglutide has the deeper weight-loss trial base, including STEP and SELECT. Oral semaglutide for weight management is supported by its own trials (the OASIS programme), which demonstrated meaningful weight loss, leading to FDA approval of the oral weight-management product.
Both are FDA-approved semaglutide, so both carry the assurance of manufacturing standards and regulatory review that compounded products lack.
The injection's evidence base is larger simply because it came first; the oral product's approval reflects its own successful trials.
Who each suits
The pill suits patients who are needle-averse, want an FDA-approved product, and can follow the empty-stomach timing rules. The injection suits patients comfortable with a weekly shot who want the deepest evidence base and, for some, the cardiovascular indication.
Cost can tip the decision for uninsured patients: the oral tablet's ~$149 starting price is attractive. But the timing rules and daily dosing are real considerations.
Compounded semaglutide is a separate, non-approved category that competes on price but not on regulatory standing.
| If you... | Consider |
|---|---|
| Dislike needles | Oral tablet |
| Want deepest evidence / CV indication | Injection |
| Want lowest approved-product cost | Oral tablet |
The bottom line
The oral Wegovy tablet offers an FDA-approved semaglutide from about $149 per month for qualifying patients, cheaper than the ~$349 injectable self-pay, at the cost of daily dosing and strict timing rules.
Both are approved products with real trial evidence. The choice comes down to cost, needle preference, dosing convenience, and clinical fit, which your clinician can help weigh.
Either approved route avoids the FDA-approval gap of compounded semaglutide.
Frequently asked questions
Is the Wegovy pill cheaper than the injection?
For qualifying self-pay patients, yes: the oral tablet starts around $149/month versus ~$349 for the injection via NovoCare.
Why does the pill use a much higher dose?
Oral semaglutide is poorly absorbed through the gut, so it needs 25mg daily to reach effective levels, versus 2.4mg weekly for the injection.
Are both FDA-approved?
Yes, both are FDA-approved semaglutide products with their own trial evidence. Compounded semaglutide is a separate, non-approved category.
Do I have to take the pill a certain way?
Yes, on an empty stomach with specific timing, because absorption is limited. Following the instructions matters for it to work.
Sources
- FDA — drug labels and compounding status (Drugs@FDA, fda.gov/drugs/human-drug-compounding).
- Provider pricing and manufacturer sources, July 2026.
- Forbes Health, U.S. News reviews, July 2026.
- Evidence policy: evidence policy.